4//SEC Filing
Sendek Joel 4
Accession 0000950170-25-113245
CIK 0000728387other
Filed
Sep 4, 8:00 PM ET
Accepted
Sep 5, 4:06 PM ET
Size
5.7 KB
Accession
0000950170-25-113245
Insider Transaction Report
Form 4
Sendek Joel
Chief Financial Officer
Transactions
- Award
Stock option (right to buy)
2025-09-04+600,000→ 600,000 totalExercise: $3.54Exp: 2035-09-04→ Common Stock (600,000 underlying)
Footnotes (1)
- [F1]The options vest over a four-year period, with one-fourth (1/4) vesting and becoming exercisable on September 4, 2026, and the remaining options vesting and becoming exercisable ratably over the following 36 months, subject to the continuous service of the Reporting Person as of each vesting date.
Documents
Issuer
Perspective Therapeutics, Inc.
CIK 0000728387
Entity typeother
Related Parties
1- filerCIK 0001720875
Filing Metadata
- Form type
- 4
- Filed
- Sep 4, 8:00 PM ET
- Accepted
- Sep 5, 4:06 PM ET
- Size
- 5.7 KB